QuickView for u0126 (compound)

1. Monocyte-derived dendritic cells treated with MEK inhibitor U0126 or p38/MAPK inhibitor SB203580
2. NIH-3T3 mouse embryonic fibroblasts expressing RasV12 treated with interferon-alpha or U0126
3. Mammary gland cancer after SHP2 knockout or SHP2 signaling inhibition
4. Fibroblasts treated with U0126 and insulin
5. Burkitt lymphoma BL-2 cells and tonsil B cells with kinase/enzyme inhibitor treatments

1. Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of te…
2. U0126 pretreatment inhibits cisplatin-induced apoptosis and autophagy in HEI-OC1 cells and cochlear …
3. The MEK inhibitor U0126 ameliorates diabetic cardiomyopathy by restricting XBP1's phosphorylation de…
4. Blockade of ERK1/2 activation with U0126 or PEP7 reduces sodium appetite and angiotensin II-induced …
5. An Addition of U0126 Protecting Heart Grafts From Prolonged Cold Ischemia-Reperfusion Injury in Hear…

There were no clinical trials for u0126